Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project
Titel:
Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project
Auteur:
Beau-Faller, Michèle Pencreach, Erwan Leduc, Charlotte Blons, Hélène Merlio, Jean-Philippe Bringuier, Pierre-Paul de Fraipont, Florence Escande, Fabienne Lemoine, Antoinette Ouafik, L'Houcine Denis, Marc Hofman, Paul Lacave, Roger Melaabi, Samia Langlais, Alexandra Missy, Pascale Morin, Franck Moro-Sibilot, Denis Barlesi, Fabrice Cadranel, Jacques